Ivermectin: a potent new antiparasitic agent.

Citations

1. Donfo-Azafack C, Nana-Djeunga HC, Wafeu-Sadeu G, Dongmo-Yemele R, Kamgno J. Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report. J Med Case Rep 2023 Apr 17;17(1):141.
   doi: 10.1186/s13256-023-03891-4pubmed: 37062821google scholar: lookup
2. Jiménez-Gaona Y, Vivanco-Galván O, Morales-Larreategui G, Cabrera-Bejarano A, Lakshminarayanan V. Outcome of Ivermectin in Cancer Treatment: An Experience in Loja-Ecuador. Nurs Rep 2023 Feb 22;13(1):315-326.
   doi: 10.3390/nursrep13010030pubmed: 36976682google scholar: lookup
3. Ryan KT, Wheeler NJ, Kamara IK, Johnson H, Humphries JE, Zamanian M, Chan JD. Phenotypic Profiling of Macrocyclic Lactones on Parasitic Schistosoma Flatworms. Antimicrob Agents Chemother 2023 Feb 16;67(2):e0123022.
   doi: 10.1128/aac.01230-22pubmed: 36695583google scholar: lookup
4. Curry E, Prichard R, Lespine A. Genetic polymorphism, constitutive expression and tissue localization of Dirofilaria immitis P-glycoprotein 11: a putative marker of macrocyclic lactone resistance. Parasit Vectors 2022 Dec 21;15(1):482.
   doi: 10.1186/s13071-022-05571-6pubmed: 36544229google scholar: lookup
5. Manavi MA, Mohammad Jafari R, Shafaroodi H, Ejtemaei-Mehr S, Sharifzadeh M, Dehpour AR. Anticonvulsant effects of ivermectin on pentylenetetrazole- and maximal electroshock-induced seizures in mice: the role of GABAergic system and K(ATP) channels. Heliyon 2022 Nov;8(11):e11375.
   doi: 10.1016/j.heliyon.2022.e11375pubmed: 36387449google scholar: lookup
6. Nakanishi A, Okumura H, Hashita T, Yamashita A, Nishimura Y, Watanabe C, Kamimura S, Hayashi S, Murakami S, Ito K, Iwao T, Ikeda A, Hirose T, Sunazuka T, Tanaka Y, Matsunaga T. Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2. Viruses 2022 Nov 8;14(11).
   doi: 10.3390/v14112468pubmed: 36366568google scholar: lookup
7. Zhang H, Xu X, Xu R, Ye T. Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis. Front Oncol 2022;12:989167.
   doi: 10.3389/fonc.2022.989167pubmed: 36132145google scholar: lookup
8. Lv S, Wu Z, Luo M, Zhang Y, Zhang J, Pascal LE, Wang Z, Wei Q. Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer. Cell Death Dis 2022 Sep 1;13(9):754.
   doi: 10.1038/s41419-022-05182-0pubmed: 36050295google scholar: lookup
9. Beckers E, Casselman I, Soudant E, Daminet S, Paepe D, Peelman L, Broeckx BJG. The prevalence of the ABCB1-1Δ variant in a clinical veterinary setting: The risk of not genotyping. PLoS One 2022;17(8):e0273706.
   doi: 10.1371/journal.pone.0273706pubmed: 36037240google scholar: lookup
10. Curry E, Traversa D, Carretón E, Kramer L, Sager H, Young L, Prichard R. Dirofilaria immitis: Genotyping Randomly Selected European Clinical Samples and USA Laboratory Isolates with Molecular Markers Associated with Macrocyclic Lactone Susceptibility and Resistance. Pathogens 2022 Aug 18;11(8).
    doi: 10.3390/pathogens11080934pubmed: 36015054google scholar: lookup
11. Muema JM, Bargul JL, Obonyo MA, Njeru SN, Matoke-Muhia D, Mutunga JM. Contemporary exploitation of natural products for arthropod-borne pathogen transmission-blocking interventions. Parasit Vectors 2022 Aug 24;15(1):298.
    doi: 10.1186/s13071-022-05367-8pubmed: 36002857google scholar: lookup
12. Cain JL, Nielsen MK. The equine ascarids: resuscitating historic model organisms for modern purposes. Parasitol Res 2022 Oct;121(10):2775-2791.
    doi: 10.1007/s00436-022-07627-zpubmed: 35986167google scholar: lookup
13. Fraccaroli L, Ruiz MD, Perdomo VG, Clausi AN, Balcazar DE, Larocca L, Carrillo C. Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids. Front Cell Infect Microbiol 2022;12:885268.
    doi: 10.3389/fcimb.2022.885268pubmed: 35967842google scholar: lookup
14. Gupta S, Vohra S, Sethi K, Gupta S, Bera BC, Kumar S, Kumar R. In vitro anti-trypanosomal effect of ivermectin on Trypanosoma evansi by targeting multiple metabolic pathways. Trop Anim Health Prod 2022 Jul 22;54(4):240.
    doi: 10.1007/s11250-022-03228-1pubmed: 35869164google scholar: lookup
15. de Souza RB, Guimarães JR. Effects of Avermectins on the Environment Based on Its Toxicity to Plants and Soil Invertebrates-a Review. Water Air Soil Pollut 2022;233(7):259.
    doi: 10.1007/s11270-022-05744-0pubmed: 35789787google scholar: lookup
16. Rezai MS, Ahangarkani F, Hill A, Ellis L, Mirchandani M, Davoudi A, Eslami G, Roozbeh F, Babamahmoodi F, Rouhani N, Alikhani A, Najafi N, Ghasemian R, Mehravaran H, Hajialibeig A, Navaeifar MR, Shahbaznejad L, Rahimzadeh G, Saeedi M, Alizadeh-Navai R, Moosazadeh M, Saeedi S, Razavi-Amoli SK, Rezai S, Rostami-Maskopaee F, Hosseinzadeh F, Movahedi FS, Markowitz JS, Valadan R. Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials. Front Med (Lausanne) 2022;9:919708.
    doi: 10.3389/fmed.2022.919708pubmed: 35783616google scholar: lookup
17. Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 2022 Jun 21;6(6):CD015017.
    doi: 10.1002/14651858.CD015017.pub3pubmed: 35726131google scholar: lookup
18. Hao Y, You Y, Chen Z, Li J, Liu G, Wen Y. Avermectin B1a production in Streptomyces avermitilis is enhanced by engineering aveC and precursor supply genes. Appl Microbiol Biotechnol 2022 Mar;106(5-6):2191-2205.
    doi: 10.1007/s00253-022-11854-wpubmed: 35258669google scholar: lookup
19. Wysmołek ME, Długosz E, Wiśniewski M. The Immunological Role of Vascular and Lymphatic Endothelial Cells in Filarial Infections. Animals (Basel) 2022 Feb 10;12(4).
    doi: 10.3390/ani12040426pubmed: 35203133google scholar: lookup
20. Piras C, Gugliandolo E, Castagna F, Palma E, Britti D. Ivermectin (IVM) Possible Side Activities and Implications in Antimicrobial Resistance and Animal Welfare: The Authors' Perspective. Vet Sci 2022 Jan 11;9(1).
    doi: 10.3390/vetsci9010024pubmed: 35051108google scholar: lookup
21. Artchayasawat A, Boueroy P, Boonmars T, Pumhirunroj B, Sriraj P, Aukkanimart R, Boonjaraspinyo S, Pitaksakulrat O, Ratanasuwan P, Suwannatrai A, Eamudomkarn C, Laummaunwai P, Zhiliang W. Efficacy of Dipterocarpus alatus oil combination with Rhinacanthus nasutus leaf and Garcinia mangostana pericarps against canine demodicosis. Vet World 2021 Nov;14(11):2919-2928.
    doi: 10.14202/vetworld.2021.2919-2928pubmed: 35017839google scholar: lookup
22. Shagufta, Ahmad I. An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity. ChemistrySelect 2021 Nov 15;6(42):11502-11527.
    doi: 10.1002/slct.202103301pubmed: 34909460google scholar: lookup
23. Lautens MJ, Tan JH, Serrat X, Del Borrello S, Schertzberg MR, Fraser AG. Identification of enzymes that have helminth-specific active sites and are required for Rhodoquinone-dependent metabolism as targets for new anthelmintics. PLoS Negl Trop Dis 2021 Nov;15(11):e0009991.
    doi: 10.1371/journal.pntd.0009991pubmed: 34843467google scholar: lookup
24. Low ZY, Yip AJW, Lal SK. Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication. Biochim Biophys Acta Mol Basis Dis 2022 Feb 1;1868(2):166294.
    doi: 10.1016/j.bbadis.2021.166294pubmed: 34687900google scholar: lookup
25. Mathachan SR, Sardana K, Khurana A. Current Use of Ivermectin in Dermatology, Tropical Medicine, and COVID-19: An Update on Pharmacology, Uses, Proven and Varied Proposed Mechanistic Action. Indian Dermatol Online J 2021 Jul-Aug;12(4):500-514.
    doi: 10.4103/idoj.idoj_298_21pubmed: 34430453google scholar: lookup
26. González-Paz L, Hurtado-León ML, Lossada C, Fernández-Materán FV, Vera-Villalobos J, Loroño M, Paz JL, Jeffreys L, Alvarado YJ. Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach. Biophys Chem 2021 Nov;278:106677.
    doi: 10.1016/j.bpc.2021.106677pubmed: 34428682google scholar: lookup
27. Popp M, Stegemann M, Metzendorf MI, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev 2021 Jul 28;7(7):CD015017.
    doi: 10.1002/14651858.CD015017.pub2pubmed: 34318930google scholar: lookup
28. Taki AC, Byrne JJ, Wang T, Sleebs BE, Nguyen N, Hall RS, Korhonen PK, Chang BCH, Jackson P, Jabbar A, Gasser RB. High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on Haemonchus contortus. Pharmaceuticals (Basel) 2021 Jun 26;14(7).
    doi: 10.3390/ph14070616pubmed: 34206910google scholar: lookup
29. Sutliff AK, Saint-Cyr M, Hendricks AE, Chen SS, Doenges KA, Quinn K, Westcott J, Tang M, Borengasser SJ, Reisdorph RM, Campbell WW, Krebs NF, Reisdorph NA. Lipidomics-Based Comparison of Molecular Compositions of Green, Yellow, and Red Bell Peppers. Metabolites 2021 Apr 14;11(4).
    doi: 10.3390/metabo11040241pubmed: 33919953google scholar: lookup
30. Bisht D, Kumar D, Kumar D, Dua K, Chellappan DK. Phytochemistry and pharmacological activity of the genus artemisia. Arch Pharm Res 2021 May;44(5):439-474.
    doi: 10.1007/s12272-021-01328-4pubmed: 33893998google scholar: lookup
31. Rendic SP. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects. Arch Toxicol 2021 May;95(5):1535-1546.
    doi: 10.1007/s00204-021-03025-zpubmed: 33719007google scholar: lookup
32. Yesilbag K, Toker EB, Ates O. Ivermectin also inhibits the replication of bovine respiratory viruses (BRSV, BPIV-3, BoHV-1, BCoV and BVDV) in vitro. Virus Res 2021 May;297:198384.
    doi: 10.1016/j.virusres.2021.198384pubmed: 33713753google scholar: lookup
33. Zhao Y, Gameiro-Ros I, Glaaser IW, Slesinger PA. Advances in Targeting GIRK Channels in Disease. Trends Pharmacol Sci 2021 Mar;42(3):203-215.
    doi: 10.1016/j.tips.2020.12.002pubmed: 33468322google scholar: lookup
34. Hahnel SR, Dilks CM, Heisler I, Andersen EC, Kulke D. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives. Int J Parasitol Drugs Drug Resist 2020 Dec;14:237-248.
    doi: 10.1016/j.ijpddr.2020.09.005pubmed: 33249235google scholar: lookup
35. Sarkar C, Mondal M, Torequl Islam M, Martorell M, Docea AO, Maroyi A, Sharifi-Rad J, Calina D. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives. Front Pharmacol 2020;11:572870.
    doi: 10.3389/fphar.2020.572870pubmed: 33041814google scholar: lookup
36. Tang M, Hu X, Wang Y, Yao X, Zhang W, Yu C, Cheng F, Li J, Fang Q. Ivermectin, a potential anticancer drug derived from an antiparasitic drug. Pharmacol Res 2021 Jan;163:105207.
    doi: 10.1016/j.phrs.2020.105207pubmed: 32971268google scholar: lookup
37. Moyo P, Mugumbate G, Eloff JN, Louw AI, Maharaj VJ, Birkholtz LM. Natural Products: A Potential Source of Malaria Transmission Blocking Drugs?. Pharmaceuticals (Basel) 2020 Sep 17;13(9).
    doi: 10.3390/ph13090251pubmed: 32957668google scholar: lookup
38. Wang Y, Gong M, Wang X, Peng X, Wang Y, Guan J, Cheng D, Weng C, Zheng Y. Efficient degradation of ivermectin by newly isolated Aeromonas taiwanensis ZJB-18,044. Biodegradation 2020 Dec;31(4-6):275-288.
    doi: 10.1007/s10532-020-09909-8pubmed: 32936376google scholar: lookup
39. Ellis JT, Ellis B, Velez-Estevez A, Reichel MP, Cobo MJ. 30 years of parasitology research analysed by text mining. Parasitology 2020 Dec;147(14):1643-1657.
    doi: 10.1017/S0031182020001596pubmed: 32867863google scholar: lookup
40. El-Saber Batiha G, Alqahtani A, Ilesanmi OB, Saati AA, El-Mleeh A, Hetta HF, Magdy Beshbishy A. Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects. Pharmaceuticals (Basel) 2020 Aug 17;13(8).
    doi: 10.3390/ph13080196pubmed: 32824399google scholar: lookup
41. Wang Z, Yang L. Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection. Front Pharmacol 2020;11:1013.
    doi: 10.3389/fphar.2020.01013pubmed: 32714193google scholar: lookup
42. Laudisi F, Marônek M, Di Grazia A, Monteleone G, Stolfi C. Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System. Int J Mol Sci 2020 Jul 13;21(14).
    doi: 10.3390/ijms21144957pubmed: 32668817google scholar: lookup
43. Singh G, Angwafor SA, Njamnshi AK, Fraimow H, Sander JW. Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries. Nat Rev Neurol 2020 Jun;16(6):333-345.
    doi: 10.1038/s41582-020-0361-3pubmed: 32427939google scholar: lookup
44. Martins DOS, Santos IA, de Oliveira DM, Grosche VR, Jardim ACG. Antivirals against Chikungunya Virus: Is the Solution in Nature?. Viruses 2020 Feb 29;12(3).
    doi: 10.3390/v12030272pubmed: 32121393google scholar: lookup
45. Alves SN, Pujoni DGF, Mocelin G, Melo AL, Serrão JE. Evaluation of Culex quinquefasciatus wings asymmetry after exposure of larvae to sublethal concentration of ivermectin. Environ Sci Pollut Res Int 2020 Jan;27(3):3483-3488.
    doi: 10.1007/s11356-019-06963-5pubmed: 31820251google scholar: lookup
46. Noskov YA, Polenogova OV, Yaroslavtseva ON, Belevich OE, Yurchenko YA, Chertkova EA, Kryukova NA, Kryukov VY, Glupov VV. Combined effect of the entomopathogenic fungus Metarhizium robertsii and avermectins on the survival and immune response of Aedes aegypti larvae. PeerJ 2019;7:e7931.
    doi: 10.7717/peerj.7931pubmed: 31667017google scholar: lookup
47. Ahmadpour E, Godrati-Azar Z, Spotin A, Norouzi R, Hamishehkar H, Nami S, Heydarian P, Rajabi S, Mohammadi M, Perez-Cordon G. Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis. Parasit Vectors 2019 Oct 10;12(1):469.
    doi: 10.1186/s13071-019-3719-xpubmed: 31601244google scholar: lookup
48. Park J, Chae JB, Kim S, Yu DH, Kim HC, Park BK, Chae JS, Choi KS. Evaluation of the efficacy of ivermectin against Theileria orientalis infection in grazing cattle. BMC Vet Res 2019 Aug 17;15(1):297.
    doi: 10.1186/s12917-019-2042-2pubmed: 31420047google scholar: lookup
49. de Carvalho LP, Sandri TL, José Tenório de Melo E, Fendel R, Kremsner PG, Mordmüller B, Held J. Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro. Antimicrob Agents Chemother 2019 Aug;63(8).
    doi: 10.1128/AAC.00085-19pubmed: 31109978google scholar: lookup
50. Deng Q, Xiao L, Liu Y, Zhang L, Deng Z, Zhao C. Streptomyces avermitilis industrial strain as cell factory for Ivermectin B1a production. Synth Syst Biotechnol 2019 Mar;4(1):34-39.
    doi: 10.1016/j.synbio.2018.12.003pubmed: 30623120google scholar: lookup
51. Ngwasiri CA, Abanda MH, Aminde LN. Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report. J Med Case Rep 2018 Sep 11;12(1):254.
    doi: 10.1186/s13256-018-1801-1pubmed: 30201032google scholar: lookup
52. Takahashi Y, Nakashima T. Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics. Antibiotics (Basel) 2018 May 24;7(2).
    doi: 10.3390/antibiotics7020045pubmed: 29795019google scholar: lookup
53. Dreyer SM, Morin KJ, Vaughan JA. Differential susceptibilities of Anopheles albimanus and Anopheles stephensi mosquitoes to ivermectin. Malar J 2018 Apr 3;17(1):148.
    doi: 10.1186/s12936-018-2296-3pubmed: 29615055google scholar: lookup
54. Khoja S, Huynh N, Warnecke AMP, Asatryan L, Jakowec MW, Davies DL. Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders. Psychopharmacology (Berl) 2018 Jun;235(6):1697-1709.
    doi: 10.1007/s00213-018-4869-9pubmed: 29500584google scholar: lookup
55. Molena RA, Peachey LE, Di Cesare A, Traversa D, Cantacessi C. Cyathostomine egg reappearance period following ivermectin treatment in a cohort of UK Thoroughbreds. Parasit Vectors 2018 Jan 25;11(1):61.
    doi: 10.1186/s13071-018-2638-6pubmed: 29370872google scholar: lookup
56. Chen IS, Kubo Y. Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin. J Physiol 2018 May 15;596(10):1833-1845.
    doi: 10.1113/JP275236pubmed: 29063617google scholar: lookup
57. Chen IS, Tateyama M, Fukata Y, Uesugi M, Kubo Y. Ivermectin activates GIRK channels in a PIP(2) -dependent, G(βγ) -independent manner and an amino acid residue at the slide helix governs the activation. J Physiol 2017 Sep 1;595(17):5895-5912.
    doi: 10.1113/JP274871pubmed: 28715108google scholar: lookup
58. Rodríguez-Hidalgo R, Pérez-Otáñez X, Garcés-Carrera S, Vanwambeke SO, Madder M, Benítez-Ortiz W. The current status of resistance to alpha-cypermethrin, ivermectin, and amitraz of the cattle tick (Rhipicephalus microplus) in Ecuador. PLoS One 2017;12(4):e0174652.
    doi: 10.1371/journal.pone.0174652pubmed: 28388639google scholar: lookup
59. Laing R, Gillan V, Devaney E. Ivermectin - Old Drug, New Tricks?. Trends Parasitol 2017 Jun;33(6):463-472.
    doi: 10.1016/j.pt.2017.02.004pubmed: 28285851google scholar: lookup
60. Ortiz AJ, Cortez V, Azzouz A, Verdú JR. Isolation and determination of ivermectin in post-mortem and in vivo tissues of dung beetles using a continuous solid phase extraction method followed by LC-ESI+-MS/MS. PLoS One 2017;12(2):e0172202.
    doi: 10.1371/journal.pone.0172202pubmed: 28207908google scholar: lookup
61. Li J, Zhang S, Zhang H, Wang H, Zhang J, Chen A, Wang J, Xiang W. Isolation and identification of new macrocyclic lactones from a genetically engineered strain Streptomyces bingchenggensis BCJ60. J Antibiot (Tokyo) 2017 Mar;70(3):297-300.
    doi: 10.1038/ja.2016.130pubmed: 27780966google scholar: lookup
62. Mathew MD, Mathew ND, Miller A, Simpson M, Au V, Garland S, Gestin M, Edgley ML, Flibotte S, Balgi A, Chiang J, Giaever G, Dean P, Tung A, Roberge M, Roskelley C, Forge T, Nislow C, Moerman D. Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity. PLoS Negl Trop Dis 2016 Oct;10(10):e0005058.
    doi: 10.1371/journal.pntd.0005058pubmed: 27755544google scholar: lookup
63. Azab A, Nassar A, Azab AN. Anti-Inflammatory Activity of Natural Products. Molecules 2016 Oct 1;21(10).
    doi: 10.3390/molecules21101321pubmed: 27706084google scholar: lookup
64. Puspitasari S, Farajallah A, Sulistiawati E, Muladno. Effectiveness of Ivermectin and Albendazole against Haemonchus contortus in Sheep in West Java, Indonesia. Trop Life Sci Res 2016 Feb;27(1):135-44.
    pubmed: 27019686
65. Wang XS, Liu C, Khoso PA, Zheng W, Li M, Li S. Autophagy response in the liver of pigeon exposed to avermectin. Environ Sci Pollut Res Int 2017 May;24(14):12767-12777.
    doi: 10.1007/s11356-016-6209-0pubmed: 26886445google scholar: lookup
66. Shen B. A New Golden Age of Natural Products Drug Discovery. Cell 2015 Dec 3;163(6):1297-300.
    doi: 10.1016/j.cell.2015.11.031pubmed: 26638061google scholar: lookup
67. Jin L, Wang R, Zhu Y, Zheng W, Han Y, Guo F, Ye FB, Li Y. Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease. Sci Rep 2015 Dec 1;5:17288.
    doi: 10.1038/srep17288pubmed: 26620317google scholar: lookup
68. Seaman JA, Alout H, Meyers JI, Stenglein MD, Dabiré RK, Lozano-Fuentes S, Burton TA, Kuklinski WS, Black WC 4th, Foy BD. Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals. BMC Genomics 2015 Oct 15;16:797.
    doi: 10.1186/s12864-015-2029-8pubmed: 26471037google scholar: lookup
69. Nasr HM, El-Demerdash FM, El-Nagar WA. Neuro and renal toxicity induced by chlorpyrifos and abamectin in rats: Toxicity of insecticide mixture. Environ Sci Pollut Res Int 2016 Jan;23(2):1852-9.
    doi: 10.1007/s11356-015-5448-9pubmed: 26403246google scholar: lookup
70. Yamashita S, Hayashi D, Nakano A, Hayashi Y, Hirama M. Total synthesis of avermectin B1a revisited. J Antibiot (Tokyo) 2016 Jan;69(1):31-50.
    doi: 10.1038/ja.2015.47pubmed: 26350782google scholar: lookup
71. Meyers JI, Gray M, Foy BD. Mosquitocidal properties of IgG targeting the glutamate-gated chloride channel in three mosquito disease vectors (Diptera: Culicidae). J Exp Biol 2015 May 15;218(Pt 10):1487-95.
    doi: 10.1242/jeb.118596pubmed: 25994632google scholar: lookup
72. Zhu XQ, Korhonen PK, Cai H, Young ND, Nejsum P, von Samson-Himmelstjerna G, Boag PR, Tan P, Li Q, Min J, Yang Y, Wang X, Fang X, Hall RS, Hofmann A, Sternberg PW, Jex AR, Gasser RB. Genetic blueprint of the zoonotic pathogen Toxocara canis. Nat Commun 2015 Feb 4;6:6145.
    doi: 10.1038/ncomms7145pubmed: 25649139google scholar: lookup
73. Greenberg RM. Ion channels and drug transporters as targets for anthelmintics. Curr Clin Microbiol Rep 2014 Dec;1(3-4):51-60.
    doi: 10.1007/s40588-014-0007-6pubmed: 25554739google scholar: lookup
74. Lynagh T, Cromer BA, Dufour V, Laube B. Comparative pharmacology of flatworm and roundworm glutamate-gated chloride channels: Implications for potential anthelmintics. Int J Parasitol Drugs Drug Resist 2014 Dec;4(3):244-55.
    doi: 10.1016/j.ijpddr.2014.07.004pubmed: 25516835google scholar: lookup
75. Dmitryjuk M, Łopieńska-Biernat E, Zaobidna EA. The in vitro effect of ivermectin on the activity of trehalose synthesis pathway enzymes and their mRNA expression in the muscle of adult female Ascaris suum (Nematoda). ScientificWorldJournal 2014;2014:936560.
    doi: 10.1155/2014/936560pubmed: 25405239google scholar: lookup
76. Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. EMBO Mol Med 2014 Oct;6(10):1263-78.
    doi: 10.15252/emmm.201404084pubmed: 25143352google scholar: lookup
77. Daeffler KN, Lester HA, Dougherty DA. Functional evaluation of key interactions evident in the structure of the eukaryotic Cys-loop receptor GluCl. ACS Chem Biol 2014 Oct 17;9(10):2283-90.
    doi: 10.1021/cb500323dpubmed: 25051140google scholar: lookup
78. Wolstenholme AJ. Ion channels and receptor as targets for the control of parasitic nematodes. Int J Parasitol Drugs Drug Resist 2011 Dec;1(1):2-13.
    doi: 10.1016/j.ijpddr.2011.09.003pubmed: 24533259google scholar: lookup
79. Pietruk K, Jedziniak P. Determination of ivermectin in medicated feeds by liquid chromatography with fluorescence detection. ScientificWorldJournal 2013;2013:362453.
    doi: 10.1155/2013/362453pubmed: 24453835google scholar: lookup
80. Tang YT, Gao X, Rosa BA, Abubucker S, Hallsworth-Pepin K, Martin J, Tyagi R, Heizer E, Zhang X, Bhonagiri-Palsikar V, Minx P, Warren WC, Wang Q, Zhan B, Hotez PJ, Sternberg PW, Dougall A, Gaze ST, Mulvenna J, Sotillo J, Ranganathan S, Rabelo EM, Wilson RW, Felgner PL, Bethony J, Hawdon JM, Gasser RB, Loukas A, Mitreva M. Genome of the human hookworm Necator americanus. Nat Genet 2014 Mar;46(3):261-269.
    doi: 10.1038/ng.2875pubmed: 24441737google scholar: lookup
81. Ali M, Afzal M, Verma M, Bhattacharya SM, Ahmad FJ, Samim M, Abidin MZ, Dinda AK. Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. Parasitol Res 2014 Feb;113(2):681-91.
    doi: 10.1007/s00436-013-3696-5pubmed: 24366812google scholar: lookup
82. Dufour V, Beech RN, Wever C, Dent JA, Geary TG. Molecular cloning and characterization of novel glutamate-gated chloride channel subunits from Schistosoma mansoni. PLoS Pathog 2013;9(8):e1003586.
    doi: 10.1371/journal.ppat.1003586pubmed: 24009509google scholar: lookup
83. Schwarz EM, Korhonen PK, Campbell BE, Young ND, Jex AR, Jabbar A, Hall RS, Mondal A, Howe AC, Pell J, Hofmann A, Boag PR, Zhu XQ, Gregory T, Loukas A, Williams BA, Antoshechkin I, Brown C, Sternberg PW, Gasser RB. The genome and developmental transcriptome of the strongylid nematode Haemonchus contortus. Genome Biol 2013 Aug 28;14(8):R89.
    doi: 10.1186/gb-2013-14-8-r89pubmed: 23985341google scholar: lookup
84. Taylor CM, Wang Q, Rosa BA, Huang SC, Powell K, Schedl T, Pearce EJ, Abubucker S, Mitreva M. Discovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathways. PLoS Pathog 2013;9(8):e1003505.
    doi: 10.1371/journal.ppat.1003505pubmed: 23935495google scholar: lookup
85. Kandeel M, Elgazar W, Kitade Y. The Binding Interactions of the Macrolide Endectocide Ivermectin with the Antibiotics Ampicillin, Chloramphenicol and Tetracycline HCL. Indian J Pharm Sci 2012 Nov;74(6):592-6.
    doi: 10.4103/0250-474X.110635pubmed: 23798790google scholar: lookup
86. Rahman MM, Na TW, Abd El-Aty AM, Park JH, Al Mahmud MN, Yang A, Park KH, Shim JH. Dissipation pattern and pre-harvest residue limit of abamectin in perilla leaves. Environ Monit Assess 2013 Nov;185(11):9461-9.
    doi: 10.1007/s10661-013-3265-5pubmed: 23729163google scholar: lookup
87. Yu X, Sun D. Macrocyclic drugs and synthetic methodologies toward macrocycles. Molecules 2013 May 24;18(6):6230-68.
    doi: 10.3390/molecules18066230pubmed: 23708234google scholar: lookup
88. Whitehorn J, Thi LV, Dui le T, Simmons CP. Aedes aegypti (L.) survival after exposure to ivermectin. Southeast Asian J Trop Med Public Health 2013 Mar;44(2):179-81.
    pubmed: 23691626
89. Brinke M, Heininger P, Traunspurger W. Effects of a bioassay-derived ivermectin lowest observed effect concentration on life-cycle traits of the nematode Caenorhabditis elegans. Ecotoxicology 2013 Jan;22(1):148-55.
    doi: 10.1007/s10646-012-1011-3pubmed: 23161368google scholar: lookup
90. Ali SW, Yu FB, Li LT, Li XH, Gu LF, Jiang JD, Li SP. Studies revealing bioremediation potential of the strain Burkholderia sp. GB-01 for abamectin contaminated soils. World J Microbiol Biotechnol 2012 Jan;28(1):39-45.
    doi: 10.1007/s11274-011-0790-7pubmed: 22806778google scholar: lookup
91. Reed TE, Daunt F, Kiploks AJ, Burthe SJ, Granroth-Wilding HM, Takahashi EA, Newell M, Wanless S, Cunningham EJ. Impacts of parasites in early life: contrasting effects on juvenile growth for different family members. PLoS One 2012;7(2):e32236.
    doi: 10.1371/journal.pone.0032236pubmed: 22384190google scholar: lookup
92. Babalola OE. Ocular onchocerciasis: current management and future prospects. Clin Ophthalmol 2011;5:1479-91.
    doi: 10.2147/OPTH.S8372pubmed: 22069350google scholar: lookup
93. Lumaret JP, Errouissi F, Floate K, Römbke J, Wardhaugh K. A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments. Curr Pharm Biotechnol 2012 May;13(6):1004-60.
    doi: 10.2174/138920112800399257pubmed: 22039795google scholar: lookup
94. Geyer J, Janko C. Treatment of MDR1 mutant dogs with macrocyclic lactones. Curr Pharm Biotechnol 2012 May;13(6):969-86.
    doi: 10.2174/138920112800399301pubmed: 22039792google scholar: lookup
95. Jex AR, Liu S, Li B, Young ND, Hall RS, Li Y, Yang L, Zeng N, Xu X, Xiong Z, Chen F, Wu X, Zhang G, Fang X, Kang Y, Anderson GA, Harris TW, Campbell BE, Vlaminck J, Wang T, Cantacessi C, Schwarz EM, Ranganathan S, Geldhof P, Nejsum P, Sternberg PW, Yang H, Wang J, Wang J, Gasser RB. Ascaris suum draft genome. Nature 2011 Oct 26;479(7374):529-33.
    doi: 10.1038/nature10553pubmed: 22031327google scholar: lookup
96. Hibbs RE, Gouaux E. Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 2011 Jun 2;474(7349):54-60.
    doi: 10.1038/nature10139pubmed: 21572436google scholar: lookup
97. Fernández C, Porcel MA, Alonso A, San Andrés M, Tarazona JV. Semifield assessment of the runoff potential and environmental risk of the parasiticide drug ivermectin under Mediterranean conditions. Environ Sci Pollut Res Int 2011 Aug;18(7):1194-201.
    doi: 10.1007/s11356-011-0474-8pubmed: 21373858google scholar: lookup
98. Crump A, Ōmura S. Ivermectin, 'wonder drug' from Japan: the human use perspective. Proc Jpn Acad Ser B Phys Biol Sci 2011;87(2):13-28.
    doi: 10.2183/pjab.87.13pubmed: 21321478google scholar: lookup
99. Hassan MU, Khan MN, Abubakar M, Waheed HM, Iqbal Z, Hussain M. Bovine hypodermosis--a global aspect. Trop Anim Health Prod 2010 Dec;42(8):1615-25.
    doi: 10.1007/s11250-010-9634-ypubmed: 20607401google scholar: lookup
100. Boonstra H, Reichman EP, van den Brink PJ. Effects of the veterinary pharmaceutical ivermectin in indoor aquatic microcosms. Arch Environ Contam Toxicol 2011 Jan;60(1):77-89.
     doi: 10.1007/s00244-010-9526-1pubmed: 20422169google scholar: lookup
101. Elissondo MC, Ceballos L, Alvarez L, Sánchez Bruni S, Lanusse C, Denegri G. Flubendazole and ivermectin in vitro combination therapy produces a marked effect on Echinococcus granulosus protoscoleces and metacestodes. Parasitol Res 2009 Sep;105(3):835-42.
     doi: 10.1007/s00436-009-1469-ypubmed: 19444468google scholar: lookup
102. McCavera S, Rogers AT, Yates DM, Woods DJ, Wolstenholme AJ. An ivermectin-sensitive glutamate-gated chloride channel from the parasitic nematode Haemonchus contortus. Mol Pharmacol 2009 Jun;75(6):1347-55.
     doi: 10.1124/mol.108.053363pubmed: 19336526google scholar: lookup
103. Bauck SW, Jim GK, Guichon PT, Newcomb KM, Cox JL, Barrick RA. Comparative cost-effectiveness of ivermectin versus topical organophosphate in feedlot calves. Can Vet J 1989 Feb;30(2):161-4.
     pubmed: 17423237
104. Barragry TB. A review of the pharmacology and clinical uses of ivermectin. Can Vet J 1987 Aug;28(8):512-7.
     pubmed: 17422843
105. Slocombe JO, Cote JF. Effectiveness of ivermectin paste for removal of nematodes in the horse. Can Vet J 1984 Oct;25(10):386-8.
     pubmed: 17422461
106. Trailović SM, Varagić VM. The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine. Vet Res Commun 2007 Oct;31(7):863-72.
     doi: 10.1007/s11259-007-0050-3pubmed: 17308985google scholar: lookup
107. Ndong TB, Kane Y, Diouf EH, Alvinerie M. Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition. Vet Res Commun 2007 Aug;31(6):739-47.
     doi: 10.1007/s11259-007-3522-6pubmed: 17260181google scholar: lookup
108. de Souza Chagas AC, da Silva Vieira L, Rodrigues Aragão W, do Carmo Navarro AM, Vasques Villela LC. Anthelmintic action of eprinomectin in lactating Anglo-Nubian goats in Brazil. Parasitol Res 2007 Jan;100(2):391-4.
     doi: 10.1007/s00436-006-0316-7pubmed: 17031697google scholar: lookup
109. Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci U S A 2004 Aug 10;101(32):11725-30.
     doi: 10.1073/pnas.0402374101pubmed: 15289602google scholar: lookup
110. Slocombe JO, McCraw BM. Evaluation of ivermectin against later fourth-stage Strongylus vulgaris in ponies at two and five weeks after treatment. Can J Comp Med 1984 Oct;48(4):343-8.
     pubmed: 6391639
111. Greenwood D. Prospects for new antibiotics: keeping one step ahead. J R Coll Physicians Lond 1985 Oct;19(4):231-4.
     pubmed: 4067896
112. Lo PK, Fink DW, Williams JB, Blodinger J. Pharmacokinetic studies of ivermectin: effects of formulation. Vet Res Commun 1985 Sep;9(4):251-68.
     doi: 10.1007/BF02215150pubmed: 3841626google scholar: lookup
113. Simpson CF, Jackson RF. Lesions in the liver and kidney of Dirofilaria immitis-infected dogs following treatment with ivermectin. Z Parasitenkd 1985;71(1):97-105.
     doi: 10.1007/BF00932923pubmed: 3838610google scholar: lookup
114. Albert J, Lingle CJ, Marder E, O'Neil MB. A GABA-activated chloride-conductance not blocked by picrotoxin on spiny lobster neuromuscular preparations. Br J Pharmacol 1986 Apr;87(4):771-9.
     doi: 10.1111/j.1476-5381.1986.tb14596.xpubmed: 3708210google scholar: lookup
115. Dadzie KY, Bird AC, Awadzi K, Schulz-Key H, Gilles HM, Aziz MA. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. Br J Ophthalmol 1987 Feb;71(2):78-85.
     doi: 10.1136/bjo.71.2.78pubmed: 3548811google scholar: lookup
116. Kaufman WR, Ungarian SG, Noga AE. The effect of avermectins on feeding, salivary fluid secretion, and fecundity in some ixodid ticks. Exp Appl Acarol 1986 Apr;2(1):1-18.
     doi: 10.1007/BF01193351pubmed: 3451859google scholar: lookup
117. Taylor HR. Onchocerciasis--a potential revolution in its treatment. Int Ophthalmol 1987 Dec;11(2):83-5.
     doi: 10.1007/BF00136735pubmed: 3446620google scholar: lookup
118. Sani BP, Vaid A. Specific interaction of ivermectin with retinol-binding protein from filarial parasites. Biochem J 1988 Feb 1;249(3):929-32.
     doi: 10.1042/bj2490929pubmed: 3355505google scholar: lookup
119. Edwards G, Breckenridge AM. Clinical pharmacokinetics of anthelmintic drugs. Clin Pharmacokinet 1988 Aug;15(2):67-93.
     doi: 10.2165/00003088-198815020-00001pubmed: 3064952google scholar: lookup
120. Newland HS, White AT, Greene BM, D'Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR. Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br J Ophthalmol 1988 Aug;72(8):561-9.
     doi: 10.1136/bjo.72.8.561pubmed: 3046657google scholar: lookup
121. Maynard MS, Maynard HD. HPLC assay for avermectin B1a and its two photoisomers using a photo diode array detector. Bull Environ Contam Toxicol 1989 Oct;43(4):499-504.
     doi: 10.1007/BF01701926pubmed: 2804390google scholar: lookup
122. White NJ. Antiparasitic drugs in children. Clin Pharmacokinet 1989;17 Suppl 1:138-55.
     doi: 10.2165/00003088-198900171-00010pubmed: 2692937google scholar: lookup
123. Vaughn DM, Simpson ST, Blagburn BL, Whitmer WL, Heddens-Mysinger R, Hendrix CM. Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin. Vet Res Commun 1989;13(1):47-55.
     doi: 10.1007/BF00366852pubmed: 2475964google scholar: lookup
124. Taylor HR. Onchocerciasis. Int Ophthalmol 1990 May;14(3):189-94.
     doi: 10.1007/BF00158317pubmed: 2188920google scholar: lookup
125. Spindler KD, Spindler-Barth M, Londershausen M. Chitin metabolism: a target for drugs against parasites. Parasitol Res 1990;76(4):283-8.
     doi: 10.1007/BF00928180pubmed: 2186405google scholar: lookup
126. Van der Lelij A, Rothova A, Klaassen-Broekema N, Wilson WR, Barbe RF, Stilma JS. Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis. Doc Ophthalmol 1990 Oct;75(3-4):215-24.
     doi: 10.1007/BF00164834pubmed: 2090395google scholar: lookup
127. Cook GC. Anthelminthic agents: some recent developments and their clinical application. Postgrad Med J 1991 Jan;67(783):16-22.
     doi: 10.1136/pgmj.67.783.16pubmed: 2057421google scholar: lookup
128. Lomas LO, Kaufman WR. Ivermectin is not an agonist at a GABA receptor in tick salivary glands. Exp Appl Acarol 1991 Sep;12(1-2):129-33.
     doi: 10.1007/BF01204406pubmed: 1660804google scholar: lookup
129. Lunke MD, Kaufman WR. Effects of the avermectin analogue MK-243 on vitellogenesis and reproduction in the ixodid tick, Amblyomma hebraeum. Exp Appl Acarol 1992 Mar;13(4):249-59.
     doi: 10.1007/BF01195082pubmed: 1526201google scholar: lookup
130. Pooda SH, Pagabeleguem S, Toé AI, Belem AMG, Mouline K, Solano P. Efficacy of high doses of ivermectin-clorsulon in cattle on Glossina palpalis gambiensis survival and fecundity: implications for human and animal trypanosomoses control. Parasit Vectors 2026 Feb 6;19(1):79.
     doi: 10.1186/s13071-026-07277-5pubmed: 41652443google scholar: lookup
131. Ryan KT, Duncan JM, Thomas CS, Chevrette MG, DenHartog ML, Labby KJ, Klein J, Zamanian M, Handelsman J. Nematicidal indole oxazoles and chemoattractants from soil bacteria. bioRxiv 2026 Jan 20;.
     doi: 10.64898/2026.01.20.700618pubmed: 41648518google scholar: lookup
132. Arnberg M, Drivdal M, Evenset A, Lillicrap A, Macken AL, Ramasco V, Skomsø DB, Sagerup K, Refseth GH. Ecological Impacts of Emamectin Benzoate, a Sea Lice Therapeutant, on Benthic Communities in the Vicinity of Norwegian Aquaculture Facilities. Environ Sci Technol 2026 Feb 3;60(4):3459-3474.
     doi: 10.1021/acs.est.5c11181pubmed: 41566218google scholar: lookup
133. Xuan M, Zhang P, Guo J, Guan F, Lu S, Liu W. Ivermectin attenuates Schistosoma japonicum-induced liver fibrosis and is associated with downregulation of YAP signaling. Front Cell Infect Microbiol 2025;15:1678067.
     doi: 10.3389/fcimb.2025.1678067pubmed: 41220567google scholar: lookup
134. Ahmad R, Lewis D, Verellen LA, Yin R, Scott A, Fruci M. The avermectin, emamectin benzoate, kills gram-positive bacteria and targets the cell envelope of Bacillus subtilis. Microbiol Spectr 2025 Oct 7;13(10):e0027425.
     doi: 10.1128/spectrum.00274-25pubmed: 40891893google scholar: lookup
135. van de Ven M, Broecke BV, Ribas A, Leirs H, Sabuni C, Mariën J. Efficiency of anthelmintic treatment and its effect on microparasite dynamics in wild Mastomys natalensis. Int J Parasitol Parasites Wildl 2025 Aug;27:101098.
     doi: 10.1016/j.ijppaw.2025.101098pubmed: 40606265google scholar: lookup
136. Rujimongkon K, Adchariyasakulchai P, Meeprasertskul P, Ketchart W. Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in endocrine-resistant breast cancer cells. PLoS One 2025;20(6):e0326742.
     doi: 10.1371/journal.pone.0326742pubmed: 40569965google scholar: lookup
137. Shukla A, Sharma A, Gupta S, Mishra A, Singh A. Antitumor potential of ivermectin against T-cell lymphoma-bearing hosts. Med Oncol 2025 Apr 21;42(5):169.
     doi: 10.1007/s12032-025-02726-0pubmed: 40257544google scholar: lookup
138. Vosála O, Krátký J, Matoušková P, Rychlá N, Štěrbová K, Raisová Stuchlíková L, Vokřál I, Skálová L. Biotransformation of anthelmintics in nematodes in relation to drug resistance. Int J Parasitol Drugs Drug Resist 2025 Apr;27:100579.
     doi: 10.1016/j.ijpddr.2025.100579pubmed: 39827513google scholar: lookup
139. Li X, Yang Y, Zhang Y, Zhang X, Zhao N, Yue W. Emamectin·chlorfenapyr-induced fatal leukoencephalomyelopathy with delayed hyperthermia: insecticide endanger public safety. Front Neurol 2024;15:1449728.
     doi: 10.3389/fneur.2024.1449728pubmed: 39711793google scholar: lookup
140. Carrillo Heredero AM, Segato G, Menotta S, Butovskaya E, Borra A, Bertini S. Advanced LC-MS/MS Technique for Environmental Ivermectin Detection. ACS Omega 2024 Oct 29;9(43):43649-43657.
     doi: 10.1021/acsomega.4c05899pubmed: 39493997google scholar: lookup
141. Fei X, Li Z, Pan Z, Liang Y, Tan C, Cheng D, Yang Q. Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway. Cancer Chemother Pharmacol 2024 Oct;94(4):599-613.
     doi: 10.1007/s00280-024-04695-zpubmed: 39235611google scholar: lookup
142. Khemrattrakool P, Hongsuwong T, Tipthara P, Kullasakboonsri R, Phanphoowong T, Sriwichai P, Hanboonkunupakarn B, Jittamala P, Tarning J, Kobylinski KC. Impact of ivermectin components on Anopheles dirus and Anopheles minimus mosquito survival. Parasit Vectors 2024 May 15;17(1):224.
     doi: 10.1186/s13071-024-06294-6pubmed: 38750608google scholar: lookup
143. Vanachayangkul P, Kodchakorn C, Ta-Aksorn W, Im-Erbsin R, Tungtaeng A, Tipthara P, Tarning J, Lugo-Roman LA, Wojnarski M, Vesely BA, Kobylinski KC. Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques. Antimicrob Agents Chemother 2024 Jun 5;68(6):e0018124.
     doi: 10.1128/aac.00181-24pubmed: 38742896google scholar: lookup
144. Davie T, Serrat X, Imhof L, Snider J, Štagljar I, Keiser J, Hirano H, Watanabe N, Osada H, Fraser AG. Identification of a family of species-selective complex I inhibitors as potential anthelmintics. Nat Commun 2024 May 8;15(1):3367.
     doi: 10.1038/s41467-024-47331-3pubmed: 38719808google scholar: lookup
145. Yahyazadeh R, Rahimi VB, Yahyazadeh A, Askari VR. A Mechanistic Review on Protective Effects of Mangosteen and its Xanthones Against Hazardous Materials and Toxins. Curr Neuropharmacol 2024;22(12):1986-2015.
     doi: 10.2174/1570159X22666240212142655pubmed: 38486389google scholar: lookup
146. Manavi MA, Toutounchian S, Afsahi S, Ebrahim Soltani Z, Mohammad Jafari R, Dehpour AR. Ivermectin Exerts Anticonvulsant Effects Against Status Epilepticus Induced by Lithium-Pilocarpine in Rats via GABA(A) Receptor and Neuroinflammation Modulation: Possible Interaction of Opioidergic Pathways and K(ATP) Channel with Nitrergic System. Mol Neurobiol 2024 Oct;61(10):7627-7638.
     doi: 10.1007/s12035-024-04061-3pubmed: 38421468google scholar: lookup
147. Pérez S, Miró MV, Verna A, Altamiranda EG, Barcos O, Lanusse C, Lifschitz A. Ivermectin antiviral activity against Varicellovirus bovinealpha 1: assessment of intracellular drug accumulation in virus-infected cells. Arch Microbiol 2024 Jan 26;206(2):78.
     doi: 10.1007/s00203-023-03806-3pubmed: 38277061google scholar: lookup
148. Damene E, Massebo F. Administration of ivermectin to cattle induced mortality, reduced fecundity and survivorship of Anopheles arabiensis in Ethiopia: an implication for expansion of vector control toolbox. Trop Med Health 2024 Jan 16;52(1):11.
     doi: 10.1186/s41182-023-00575-zpubmed: 38229204google scholar: lookup
149. Valvecchia F, Greco L, Perrone F, Logioco C, Caride GG, Perrone L, Valvecchia G, Albertazzi R, Zanutigh V. Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study. Graefes Arch Clin Exp Ophthalmol 2024 Apr;262(4):1281-1288.
     doi: 10.1007/s00417-023-06281-0pubmed: 37910180google scholar: lookup
150. Reisenauer KN, Aroujo J, Tao Y, Ranganathan S, Romo D, Taube JH. Therapeutic vulnerabilities of cancer stem cells and effects of natural products. Nat Prod Rep 2023 Aug 16;40(8):1432-1456.
     doi: 10.1039/d3np00002hpubmed: 37103550google scholar: lookup
151. Noack S, Harrington J, Carithers DS, Kaminsky R, Selzer PM. Heartworm disease - Overview, intervention, and industry perspective. Int J Parasitol Drugs Drug Resist 2021 Aug;16:65-89.
     doi: 10.1016/j.ijpddr.2021.03.004pubmed: 34030109google scholar: lookup